Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
02 Aug 2024
Historique:
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 31 7 2024
Statut: ppublish

Résumé

Receptor activity-modifying proteins (RAMPs) form complexes with G protein-coupled receptors (GPCRs) and may regulate their cellular trafficking and pharmacology. RAMP interactions have been identified for about 50 GPCRs, but only a few GPCR-RAMP complexes have been studied in detail. To elucidate a comprehensive GPCR-RAMP interactome, we created a library of 215 dual epitope-tagged (DuET) GPCRs representing all GPCR subfamilies and coexpressed each GPCR with each of the three RAMPs. Screening the GPCR-RAMP pairs with customized multiplexed suspension bead array (SBA) immunoassays, we identified 122 GPCRs that showed strong evidence for interaction with at least one RAMP. We screened for interactions in three cell lines and found 23 endogenously expressed GPCRs that formed complexes with RAMPs. Mapping the GPCR-RAMP interactome expands the current system-wide functional characterization of RAMP-interacting GPCRs to inform the design of selective therapeutics targeting GPCR-RAMP complexes.

Identifiants

pubmed: 39083597
doi: 10.1126/sciadv.ado9959
doi:

Substances chimiques

Receptors, G-Protein-Coupled 0
Receptor Activity-Modifying Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado9959

Auteurs

Ilana B Kotliar (IB)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.
Tri-Institutional PhD Program in Chemical Biology, New York, NY, USA.

Annika Bendes (A)

Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.

Leo Dahl (L)

Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.

Yuanhuang Chen (Y)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.
Tri-Institutional PhD Program in Chemical Biology, New York, NY, USA.

Marcus Saarinen (M)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Emilie Ceraudo (E)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.

Tea Dodig-Crnković (T)

Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.

Mathias Uhlén (M)

Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.

Per Svenningsson (P)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Basal and Clinical Neuroscience, King's College London, London, UK.

Jochen M Schwenk (JM)

Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.

Thomas P Sakmar (TP)

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.
Department of Neurobiology, Care Sciences and Society, Section for Neurogeriatrics, Karolinska Institutet, Solna, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH